Pure Global AI
ANVISA registration 10337680185Active

CATECHOLAMINE (NOREPINEPHRINE, EPINEPHRINE, DOPAMINE AND DERIVATIVES)

ANVISA Registration Number: 10337680185GENESE PRODUTOS DIAGNOSTICOS LTDADIASOURCE IMMUNOASSAY SARisk Class II
Verified
Device names
Technical name
CATECHOLAMINE (NOREPINEPHRINE, EPINEPHRINE, DOPAMINE AND DERIVATIVES)
View exact technical-name matches →
PT: CATECOLAMINA (NORADRENALINA, ADRENALINA, DOPAMINA E DERIVADOS)
Commercial name
2-CAT ELISA
View exact commercial-name matches →
Risk class
Class II
Registration details
Registration Number
10337680185
Process Number
25351286786201204
CNPJ
68384155000102
Company information
Registration Holder
GENESE PRODUTOS DIAGNOSTICOS LTDA
Manufacturer
DIASOURCE IMMUNOASSAY SA
Manufacturing Country
Belgium
PT: BÉLGICA
Dates and status
Publication Date
Jul 23, 2012
Status
Active
Official value: VIGENTE
About this record

Access comprehensive regulatory information for CATECHOLAMINE (NOREPINEPHRINE, EPINEPHRINE, DOPAMINE AND DERIVATIVES) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10337680185 and manufactured by DIASOURCE IMMUNOASSAY SA. The registration is held by GENESE PRODUTOS DIAGNOSTICOS LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.